These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease. Nakashima K; Shimoda M; Kuno N; Takahashi K Mov Disord; 1994 Jan; 9(1):106-7. PubMed ID: 8139589 [No Abstract] [Full Text] [Related]
23. A clinical review of statins and cancer: helpful or harmful? Gonyeau MJ; Yuen DW Pharmacotherapy; 2010 Feb; 30(2):177-94. PubMed ID: 20099992 [TBL] [Abstract][Full Text] [Related]
24. (-)Deprenyl in perspective: prophylaxis for Parkinson's disease? Sandler M J Neural Transm Suppl; 1986; 22():107-15. PubMed ID: 3097254 [TBL] [Abstract][Full Text] [Related]
25. [Drug-induced Parkinson's syndrome]. Degkwitz R Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182 [No Abstract] [Full Text] [Related]
26. Selegiline as neuroprotective therapy in Parkinson's disease: concepts and controversies. Langston JW Neurology; 1990 Oct; 40(10 Suppl 3):suppl 61-6; discussion 67-9. PubMed ID: 2120617 [No Abstract] [Full Text] [Related]
27. Threats, opportunities, and statins in the modern management of heart failure. Cleland JG; Loh H; Windram J; Goode K; Clark AL Eur Heart J; 2006 Mar; 27(6):641-3. PubMed ID: 16490737 [No Abstract] [Full Text] [Related]
28. Prospective study of coffee consumption and risk of Parkinson's disease. Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612 [TBL] [Abstract][Full Text] [Related]
29. Holding on to statins in Parkinson disease. Tan EK; Tan LC Neurology; 2013 Jul; 81(5):406-7. PubMed ID: 23884043 [No Abstract] [Full Text] [Related]
30. [Hyperlipidemia: decreasing lipid values and effects of statins]. Mathes P Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762 [No Abstract] [Full Text] [Related]
36. [Statins in secondary prevention of coronary heart disease]. Sandhofer F Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003 [TBL] [Abstract][Full Text] [Related]
37. Clinical inquiries. Do statins reduce the risk of stroke? Busch N; Kelsberg G; Kendall SK; Krist A J Fam Pract; 2004 Jul; 53(7):575-7. PubMed ID: 15251101 [No Abstract] [Full Text] [Related]
38. Parkinson's syndrome--modern therapy, known facts and unanswered questions. Albert E Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep; 6(5):229-46. PubMed ID: 4604872 [No Abstract] [Full Text] [Related]
39. Parkinson's disease in 1984: an update. Lang AE; Blair RD Can Med Assoc J; 1984 Nov; 131(9):1031-7. PubMed ID: 6388779 [TBL] [Abstract][Full Text] [Related]
40. Statins in the secondary prevention of stroke. Risks or benefits? Castilla-Guerra L; Alvarez-Suero J; Fernández-Moreno Mdel C Eur J Intern Med; 2009 Jan; 20(1):e22. PubMed ID: 19237075 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]